» Articles » PMID: 33068223

Amelioration of Oxidative Stress and Neuroinflammation in Lipopolysaccharide-induced Memory Impairment Using Rosmarinic Acid in Mice

Overview
Journal Metab Brain Dis
Publisher Springer
Specialties Endocrinology
Neurology
Date 2020 Oct 17
PMID 33068223
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress plays a pivotal part in the manifestation of neuroinflammation, which further leads to neurodegenerative diseases like Alzheimer's disease (AD). Systemic administration of lipopolysaccharide (LPS) induces neuroinflammation resulting in memory impairment (MI) and cognitive decline. In this study, we evaluated whether prophylactic administration of Rosmarinic acid (RA), a naturally occurring compound, exerts a neuroprotective effect in LPS-induced MI and cognitive decline. Herein, Swiss albino mice were pre-treated with RA (0.5 mg/kg and 1 mg/kg i.p.) for 28 days and were intermittently exposed to LPS (0.25 mg/kg i.p.) for 7 days. LPS caused poor memory retention and increased cognitive decline in Morris water maze (MWM) and Y maze paradigms respectively. Additionally, LPS increased oxidative stress which was denoted by a decrease in superoxide dismutase (SOD) activity, decrease in reduced glutathione (GSH) levels, and increased lipid peroxidation in the brain. Imbalance in the cholinergic system was analyzed by measuring the acetylcholinesterase (AChE) activity. Pre-treatment with RA improved memory and behavioral disturbances by alleviating oxidative stress and AChE activity. LPS augmented levels of tumor necrosis factor (TNF-α), interleukin (IL)-6, caspase-3, and c-Jun. Pre-treatment with RA revitalized the elevated levels of proinflammatory cytokines and apoptotic proteins. In conclusion, this study showcases the amelioration of MI by RA in LPS-challenged memory and cognitive decline, which could be credited to its anti-oxidant effect, inhibitory effect on both proinflammatory cytokines and apoptotic regulators, and reduction in AChE activity.

Citing Articles

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Flieger J, Forma A, Flieger W, Flieger M, Gawlik P, Dzierzynski E Int J Mol Sci. 2024; 25(16).

PMID: 39201668 PMC: 11354426. DOI: 10.3390/ijms25168982.


Kojic acid reverses LPS-induced neuroinflammation and cognitive impairment by regulating the TLR4/NF-κB signaling pathway.

Ali W, Choe K, Park J, Ahmad R, Park H, Kang M Front Pharmacol. 2024; 15:1443552.

PMID: 39185307 PMC: 11341365. DOI: 10.3389/fphar.2024.1443552.


Novel Insights into Changes in Gene Expression within the Hypothalamus in Two Asthma Mouse Models: A Transcriptomic Lung-Brain Axis Study.

Bastawy E, Eraslan I, Voglsanger L, Suphioglu C, Walker A, Dean O Int J Mol Sci. 2024; 25(13).

PMID: 39000495 PMC: 11242700. DOI: 10.3390/ijms25137391.


Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans models.

Chen Y, Xu R, Liu Q, Zeng Y, Chen W, Liu Y Mol Neurobiol. 2024; 61(12):10138-10158.

PMID: 38703342 DOI: 10.1007/s12035-024-04206-4.


Knockdown and inhibition of hippocampal GPR17 attenuates lipopolysaccharide-induced cognitive impairment in mice.

Liang Y, Kang X, Zhang H, Xu H, Wu X J Neuroinflammation. 2023; 20(1):271.

PMID: 37990234 PMC: 10662506. DOI: 10.1186/s12974-023-02958-9.


References
1.
Aarsland D . Cognitive impairment in Parkinson's disease and dementia with Lewy bodies. Parkinsonism Relat Disord. 2015; 22 Suppl 1:S144-8. DOI: 10.1016/j.parkreldis.2015.09.034. View

2.
Abdel-Azeem A, Hegazy A, Zeidan H, Ibrahim K, El-Sayed E . Potential Renoprotective Effects of Rosemary and Thyme Against Gentamicin Toxicity in Rats. J Diet Suppl. 2016; 14(4):380-394. DOI: 10.1080/19390211.2016.1253632. View

3.
Adomako-Bonsu A, Chan S, Pratten M, Fry J . Antioxidant activity of rosmarinic acid and its principal metabolites in chemical and cellular systems: Importance of physico-chemical characteristics. Toxicol In Vitro. 2017; 40:248-255. DOI: 10.1016/j.tiv.2017.01.016. View

4.
Ahmad W, Ijaz B, Shabbiri K, Ahmed F, Rehman S . Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation. J Biomed Sci. 2017; 24(1):76. PMC: 5606025. DOI: 10.1186/s12929-017-0379-z. View

5.
Alexandris A, Walker L, Liu A, McAleese K, Johnson M, Pearce R . Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders. Neuropathol Appl Neurobiol. 2019; 46(3):264-278. DOI: 10.1111/nan.12577. View